Marktanalyse - Calming and Sleeping in Germany

OTC calming and sleeping products were able to grow in Germany for the second year in a row in 2011, by almost 2% to reach €199 million. A large and, according to industry experts, still growing proportion of the population suffers from sleeping disorders and high stress levels due to work, family or finance related worries, and as long as these disorders are of minor dimension only, try to counteract them by using OTC calming and sleeping products.

Euromonitor International's Calming and Sleeping in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

CALMING AND SLEEPING IN GERMANY

Euromonitor International

July 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Calming and Sleeping: Value 2006-2011

Table 2 Sales of Calming and Sleeping: % Value Growth 2006-2011

Table 3 Calming and Sleeping Company Shares by Value 2007-2011

Table 4 Calming and Sleeping Brand Shares by Value 2008-2011

Table 5 Forecast Sales of Calming and Sleeping: Value 2011-2016

Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

GlaxoSmithKline GmbH & Co Kg in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 1 GlaxoSmithKline GmbH & Co KG: Key Facts

Summary 2 GlaxoSmithKline GmbH & Co KG: Operational Indicators

Company Background

Production

Summary 3 GlaxoSmithKline GmbH & Co KG: Production Statistics 2011

Competitive Positioning

Summary 4 GlaxoSmithKline GmbH & Co KG: Competitive Position 2011

Mann Chem-pharm Fabrik Gmbh, Dr Gerhard in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 5 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Key Facts

Summary 6 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 7 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Competitive Position 2011

Stada Arzneimittel AG in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 8 STADA Arzneimittel AG: Key Facts

Summary 9 STADA Arzneimittel AG: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 10 STADA Arzneimittel AG: Competitive Position 2011

Executive Summary

Consumer Health Overall Stagnating in Germany in 2011

Market Under Pressure From Healthier Diets and More Exercise

Very Fragmented Market Continues To Be Led by Bayer Vital

Consumer Healthcare Most Often Sold in Health and Beauty Retailers

Small Decline of Consumer Health Expected Over Forecast Period in Germany

Key Trends and Developments

Ongoing Relatively Favourable Economic Conditions in Germany in 2011

Demographic Changes Continue To Influence Consumer Health in Germany

Increasing Shares of Sales Through Internet Retailing in Consumer Health

Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers

Innovation Essential for Premium Brands To Thrive in Consumer Health

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 8 Life Expectancy at Birth 2006-2011

Market Data

Table 9 Sales of Consumer Health by Category: Value 2006-2011

Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 11 Consumer Health Company Shares 2007-2011

Table 12 Consumer Health Brand Shares 2008-2011

Table 13 Penetration of Private Label by Category 2006-2011

Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Switches

Summary 11 OTC - Switches 2010-2011

Definitions

Sources

Summary 12 Research Sources

• Calming and Sleeping in Argentina
• Calming and Sleeping in Canada
• Calming and Sleeping in Denmark
• Calming and Sleeping in Guatemala
• Calming and Sleeping in Hong Kong, China
• Calming and Sleeping in Norway
• Calming and Sleeping in Turkey
• Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
• Cough, Cold and Allergy (Hay Fever) Remedies in Canada
• Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
• Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
• Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
• Cough, Cold and Allergy (Hay Fever) Remedies in Norway
• Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
• Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
• Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
• Ear Care in Argentina
• Ear Care in Canada
• Ear Care in Denmark
• Ear Care in Hong Kong, China